Daily Health Pharmacy

Category: Medicines - Page 3

Roger Donoghue 2 February 2026 11
GMP for Generics: FDA Requirements for Manufacturing

GMP for Generics: FDA Requirements for Manufacturing

CGMP is the strict FDA standard ensuring generic drugs are as safe and effective as brand-name versions. Learn the key requirements, common violations, costs, and how compliance protects patients.

View More
Roger Donoghue 31 January 2026 14
Patent Law and Generics: How Patents Protect Innovation in Pharmaceuticals

Patent Law and Generics: How Patents Protect Innovation in Pharmaceuticals

Patent law in pharmaceuticals balances innovation and access. The Hatch-Waxman Act lets generics enter after patents expire, saving billions. But evergreening and pay-for-delay deals threaten fair competition.

View More
Roger Donoghue 27 January 2026 13
How to Use Tier Exceptions to Lower Your Medication Copays

How to Use Tier Exceptions to Lower Your Medication Copays

Learn how to request a tier exception to lower your Medicare Part D drug copays-step by step. Save hundreds a year by moving high-cost meds to lower tiers with your doctor’s help.

View More
Roger Donoghue 26 January 2026 13
Medication-Induced Acute Angle-Closure Glaucoma: The Silent Eye Emergency

Medication-Induced Acute Angle-Closure Glaucoma: The Silent Eye Emergency

Medication-induced acute angle-closure glaucoma is a sudden, painful eye emergency that can cause permanent blindness within hours. Learn which common drugs trigger it, who's at risk, and how to prevent vision loss.

View More
Roger Donoghue 26 January 2026 14
VA Generic Coverage: How Veterans Affairs Formularies Work and What Medications Are Covered

VA Generic Coverage: How Veterans Affairs Formularies Work and What Medications Are Covered

Learn how the VA National Formulary works, what generic drugs are covered, how copays work, and how to get your prescriptions through Meds by Mail or Community Care. Save money with VA's low-cost, generic-first system.

View More
Roger Donoghue 23 January 2026 8
Post-Marketing Pharmacovigilance: How New Medication Side Effects Are Found

Post-Marketing Pharmacovigilance: How New Medication Side Effects Are Found

Post-marketing pharmacovigilance catches dangerous side effects that clinical trials miss. Learn how global systems track drug safety after approval, why reports are underused, and how AI and patient data are changing the game.

View More
Roger Donoghue 21 January 2026 11
FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained

FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained

The FDA Office of Generic Drugs ensures safe, affordable generic medications reach patients by reviewing applications, enforcing bioequivalence standards, and managing patent and exclusivity rules under GDUFA and Hatch-Waxman.

View More
Roger Donoghue 20 January 2026 14
How to Store Medications to Prevent Early Expiration

How to Store Medications to Prevent Early Expiration

Learn how to store medications properly to avoid early expiration, prevent waste, and ensure your medicine works when you need it. Avoid common mistakes like keeping pills in the bathroom or near heat.

View More
Roger Donoghue 19 January 2026 8
How to Follow Professional Society Safety Updates on Medications

How to Follow Professional Society Safety Updates on Medications

Learn how to track critical medication safety updates from ISMP, FDA, ASHP, and WHO to prevent preventable errors. Get practical steps, free resources, and expert insights to stay current without being overwhelmed.

View More
Roger Donoghue 18 January 2026 13
Statins in Liver Disease: Safety and Cardiovascular Benefits Explained

Statins in Liver Disease: Safety and Cardiovascular Benefits Explained

Statins are safe and beneficial for people with liver disease, reducing cardiovascular risk and even protecting the liver. Evidence shows they lower mortality, prevent bleeding, and are well-tolerated-even in cirrhosis.

View More